 | | PRD_900013 | | Name: | SUCROSE OCTASULFATE | | Formula: | C12 H22 O35 S8 | | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900015 | | Name: | ALPHA-CYCLODEXTRIN (CYCLOHEXA-AMYLOSE) | | Formula: | C36 H60 O30 | | Description: | cyclic oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900037 | | Name: | 6-O-alpha-D-galactopyranosyl-alpha-D-glucopyranose | | Formula: | C12 H22 O11 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900041 | | Name: | BETA-D-GALACTOPYRANOSYL-1-6-BETA-D-GLUCOPYRANOSE | | Formula: | C12 H22 O11 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900055 | | Name: | 6-O-alpha-D-Glucosyl-beta-cyclodextrin | | Formula: | C48 H80 O40 | | Description: | cyclic oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900058 | | Name: | (4S,5R,6R)-6-((2R,3R,4R,5R,6R)-3-ACETAMIDO-2,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-4-YLOXY)-4,5-DIHYDROXY-5
,6-DIHYDRO-4H-PYRAN-2-CARBOXYLIC ACID | | Formula: | C14 H21 N O11 | | Description: | oligosaccharide with ring modification on monosaccharide components | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900059 | | Name: | [(2R,3S,4S,5S)-2,5-bis(hydroxymethyl)-5-[(2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-4-oxidany
l-oxolan-3-yl] [(2R,3R,4S,5S)-2,4,5-tris(oxidanyl)oxan-3-yl] hydrogen phosphate | | Formula: | C17 H31 O18 P | | Description: | oligosaccharide with Phosphate connecting between monosaccharides | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900069 | | Name: | 6-O-(6-O-phosphono-beta-D-glucopyranosyl)-beta-D-glucopyranose | | Formula: | C12 H23 O14 P | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900079 | | Name: | HEPARIN HEPTASACCHARIDE | | Formula: | C55 H98 O54 S6 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900086 | | Name: | Methyl-cyclo-hepta-amylose | | Formula: | C49 H84 O35 | | Description: | cyclic oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900094 | | Name: | HEPARIN DISACCHARIDE III-S | | Formula: | C12 H16 N O16 S2 | | Description: | oligosaccharide with ring modification on monosaccharide components | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900103 | | Name: | beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyranosyl-(1->4)-4-thio-beta-D-xylopyr
anose | | Formula: | C20 H34 O14 S3 | | Description: | oligosaccharide with S-glycosidic bond between monosaccharides | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900105 | | Name: | METHYL4,4II,4III,4IV-TETRATHIO-BETA-D-XYLOPENTOSIDE | | Formula: | C26 H44 O17 S4 | | Description: | oligosaccharide with S-glycosidic bond between monosaccharides | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900118 | | Name: | 6-O-alpha-D-mannopyranosyl-alpha-D-mannopyranose | | Formula: | C12 H22 O11 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_002270 | | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | | Formula: | C28 H44 N8 O5 | | Definition date: | 2017-06-28 | | Last modified: | 2020-06-21 |
|
 | | PRD_001136 | | Name: | SUGAR (6-MER) | | Formula: | C57 H82 O26 | | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | | Definition date: | 2013-07-26 | | Last modified: | 2020-04-04 |
|
 | | PRD_002368 | | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | | Formula: | C32 H44 N4 O4 | | Definition date: | 2019-10-02 | | Last modified: | 2019-10-02 |
|
 | | PRD_002333 | | Name: | Pseudoxylallemycin A | | Formula: | C32 H44 N4 O4 | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002334 | | Name: | Linear tetrapeptide related to pseudoxylallemycin A | | Formula: | C32 H46 N4 O5 | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002306 | | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | | Formula: | C54 H77 N9 O12 | | Definition date: | 2019-06-04 | | Last modified: | 2019-06-04 |
|
 | | PRD_002311 | | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | | Formula: | C57 H96 N10 O12 | | Definition date: | 2019-05-29 | | Last modified: | 2019-05-29 |
|
 | | PRD_002316 | | Name: | Apollo peptide | | Formula: | C46 H68 N8 O7 | | Definition date: | 2019-02-13 | | Last modified: | 2019-02-13 |
|
 | | PRD_002317 | | Name: | N-Me-p-iodo-D-Phe1,N-Me-D-Gln4,Lys10-teixobactin analogue | | Formula: | C59 H99 I N13 O15 | | Definition date: | 2018-10-17 | | Last modified: | 2018-10-17 |
|
 | | PRD_002324 | | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | | Formula: | C62 H111 N11 O13 | | Definition date: | 2018-09-12 | | Last modified: | 2018-09-12 |
|
 | | PRD_002302 | | Name: | benzyl [(6S,7S,10S,13S,18Z)-18-amino-10-cyclohexyl-6-hydroxy-18-imino-7-(2-methylpropyl)-4,9,12-trioxo-1-phenyl-16-oxa-3,8,11,17-tetraazaoctadecan-13-yl]carbamate | | Formula: | C37 H55 N7 O7 | | Definition date: | 2018-06-13 | | Last modified: | 2018-06-13 |
|
